Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:xenobiotic
go back to main search page
Accession:CHEBI:35703 term browser browse the term
Definition:A xenobiotic (Greek, xenos 'foreign'; bios 'life') is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
Synonyms:exact_synonym: xenobiotics
 related_synonym: xenobiotic compounds
 alt_id: CHEBI:10074;   CHEBI:27333
 xref: KEGG:C06708;   Wikipedia:Xenobiotic


show annotations for term's descendants           Sort by:
2,3,7,8-tetrachlorodibenzodioxine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions EXP [2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin; [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin; [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein CTD PMID:24389113 NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions EXP [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein CTD PMID:24389113 NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 increases expression EXP Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA; Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein CTD PMID:8660662 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903 		JBrowse link
G TERT telomerase reverse transcriptase decreases expression EXP Tetrachlorodibenzodioxin results in decreased expression of TERT protein CTD PMID:23850740 NCBI chr34:11,288,622...11,307,790
Ensembl chr34:11,288,622...11,307,951 		JBrowse link
9,10-phenanthroquinone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CPNE6 copine 6 increases reduction EXP DHRS4 protein results in increased reduction of 9,10-phenanthrenequinone CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744 		JBrowse link
acetophenone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALPI alkaline phosphatase, intestinal increases chemical synthesis EXP ALPI protein results in increased chemical synthesis of acetophenone CTD PMID:1495895 NCBI chr25:44,107,418...44,110,947 JBrowse link
antipyrine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Antipyrine results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819 		JBrowse link
atenolol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin multiple interactions EXP Atenolol inhibits the reaction [Isoproterenol results in increased activity of REN protein] CTD PMID:6103674 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012 		JBrowse link
clotrimazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Clotrimazole results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347 		JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 affects binding
increases activity		 EXP Clotrimazole binds to NR1I3 protein
Clotrimazole results in increased activity of NR1I3 protein; Clotrimazole results in increased activity of NR1I3 protein mutant form		 CTD PMID:21778469 PMID:27732639 NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827 		JBrowse link
cyclophosphamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2B6 cytochrome P450 2B11 increases hydroxylation EXP CYP2B6 protein results in increased hydroxylation of Cyclophosphamide CTD PMID:16546968 NCBI chr 1:112,817,561...112,833,294
Ensembl chr 1:112,816,502...112,833,293 		JBrowse link
dexamethasone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AVP arginine vasopressin decreases expression EXP Dexamethasone results in decreased expression of AVP protein CTD PMID:1934541 NCBI chr24:18,183,057...18,184,827
Ensembl chr24:18,183,057...18,184,883 		JBrowse link
G HSD11B1 hydroxysteroid 11-beta dehydrogenase 1 increases expression EXP Dexamethasone results in increased expression of HSD11B1 mRNA CTD PMID:21798686 NCBI chr 7:8,344,380...8,409,901
Ensembl chr 7:8,344,447...8,409,897 		JBrowse link
G NPPA natriuretic peptide A increases expression EXP Dexamethasone results in increased expression of NPPA protein CTD PMID:1934541 NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385 		JBrowse link
dextromethorphan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2B6 cytochrome P450 2B11 increases metabolic processing EXP CYP2B6 protein results in increased metabolism of Dextromethorphan CTD PMID:12637241 NCBI chr 1:112,817,561...112,833,294
Ensembl chr 1:112,816,502...112,833,293 		JBrowse link
G CYP2D15 cytochrome P450 family 2 subfamily D member 15 affects metabolic processing EXP CYP2D15 affects the metabolism of Dextromethorphan CTD PMID:7786018 NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298 		JBrowse link
diazepam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C18 cytochrome P450 2C21 affects metabolic processing EXP CYP2C19 protein affects the metabolism of Diazepam CTD PMID:15801540 NCBI chr28:8,727,010...8,750,427
Ensembl chr28:8,727,019...8,750,587 		JBrowse link
G CYP3A12 cytochrome P-450 3A12 multiple interactions
increases hydroxylation		 EXP Ketoconazole inhibits the reaction [CYP3A12 protein results in increased hydroxylation of Diazepam] CTD PMID:15677349
diclofenac term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C18 cytochrome P450 2C21 increases hydroxylation EXP CYP2C19 protein results in increased hydroxylation of Diclofenac CTD PMID:15677349 NCBI chr28:8,727,010...8,750,427
Ensembl chr28:8,727,019...8,750,587 		JBrowse link
G CYP2C41 cytochrome P450 2C41 affects metabolic processing EXP CYP2C9 protein affects the metabolism of Diclofenac CTD PMID:15801540
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Diclofenac results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819 		JBrowse link
ibuprofen term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Ibuprofen results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 increases expression EXP Ibuprofen results in increased expression of PTGS2 protein CTD PMID:16105799 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903 		JBrowse link
indometacin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HEXB hexosaminidase subunit beta multiple interactions EXP Indomethacin promotes the reaction [mastoparan results in increased secretion of HEXB protein] CTD PMID:21671308 NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417 		JBrowse link
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Indomethacin results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819 		JBrowse link
metoprolol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ATP2A2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of ATP2A2 protein CTD PMID:18820026 NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388 		JBrowse link
G CYP2D15 cytochrome P450 family 2 subfamily D member 15 affects metabolic processing EXP CYP2D15 affects the metabolism of Metoprolol CTD PMID:7786018 NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298 		JBrowse link
G EGR1 early growth response 1 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of EGR1 protein CTD PMID:18820026 NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575 		JBrowse link
G GATA4 GATA binding protein 4 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of GATA4 protein CTD PMID:18820026 NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989 		JBrowse link
G NAB1 NGFI-A binding protein 1 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of NAB1 protein CTD PMID:18820026 NCBI chr37:1,207,619...1,243,546
Ensembl chr37:1,207,638...1,241,610 		JBrowse link
G SLC8A1 solute carrier family 8 member A1 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of SLC8A1 protein CTD PMID:18820026 NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700 		JBrowse link
nitroglycerin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin decreases activity EXP Nitroglycerin results in decreased activity of REN protein CTD PMID:8640982 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012 		JBrowse link
pantoprazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC22A6 solute carrier family 22 member 6 multiple interactions EXP [Pantoprazole results in decreased activity of SLC22A6 protein] which results in decreased uptake of Indican CTD PMID:36243147 NCBI chr18:53,736,669...53,745,001
Ensembl chr18:53,736,959...53,744,396 		JBrowse link
paracetamol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Acetaminophen results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819 		JBrowse link
G UGT1A6 UDP glucuronosyltransferase 1 family, polypeptide A6 increases glucuronidation EXP UGT1A6 protein results in increased glucuronidation of Acetaminophen CTD PMID:11903872 NCBI chr25:45,081,655...45,161,584
Ensembl chr25:45,032,130...45,160,941 		JBrowse link
phenacetin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 affects metabolic processing EXP CYP1A2 protein affects the metabolism of Phenacetin CTD PMID:15801540 NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135 		JBrowse link
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Phenacetin results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819 		JBrowse link
prochloraz term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions EXP [2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz; [prochloraz binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein; [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz CTD PMID:24389113 NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions EXP [prochloraz binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein CTD PMID:24389113 NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866 		JBrowse link
propranolol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRB2 adrenoceptor beta 2 multiple interactions EXP [Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased secretion of Norepinephrine CTD PMID:2884805 NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298 		JBrowse link
G NPPA natriuretic peptide A increases expression EXP Propranolol results in increased expression of NPPA protein CTD PMID:2566282 NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385 		JBrowse link
G REN renin multiple interactions
decreases activity		 EXP Propranolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]
Propranolol results in decreased activity of REN protein		 CTD PMID:2566282 PMID:6103674 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012 		JBrowse link
G VIP vasoactive intestinal peptide decreases expression EXP Propranolol results in decreased expression of VIP protein CTD PMID:2566282 NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700 		JBrowse link
ritonavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP allicin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] CTD PMID:15266218 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Ritonavir results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347 		JBrowse link
spironolactone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BAX BCL2 associated X, apoptosis regulator decreases expression EXP Spironolactone results in decreased expression of BAX protein CTD PMID:20082611 NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464 		JBrowse link
G BCL2 BCL2 apoptosis regulator increases expression EXP Spironolactone results in increased expression of BCL2 protein CTD PMID:20082611 NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658 		JBrowse link
G CAPN1 calpain 1 decreases expression EXP Spironolactone results in decreased expression of CAPN1 protein CTD PMID:20082611 NCBI chr18:51,983,266...52,010,831
Ensembl chr18:51,983,824...52,010,757 		JBrowse link
G CASP3 caspase 3 decreases expression EXP Spironolactone results in decreased expression of CASP3 protein CTD PMID:20082611 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505 		JBrowse link
G CAST calpastatin increases expression EXP Spironolactone results in increased expression of CAST protein CTD PMID:20082611 NCBI chr 3:12,920,514...13,031,974
Ensembl chr 3:12,922,453...13,031,959 		JBrowse link
G MMP9 matrix metallopeptidase 9 decreases expression EXP Spironolactone results in decreased expression of MMP9 protein CTD PMID:20082611 NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293 		JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 increases expression EXP Spironolactone results in increased expression of TIMP1 protein CTD PMID:20082611 NCBI chr  X:41,201,623...41,205,314
Ensembl chr  X:41,201,638...41,205,310 		JBrowse link
tebuconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC22A2 solute carrier family 22 member 2 decreases activity EXP tebuconazole results in decreased activity of SLC22A2 protein CTD PMID:36669674 NCBI chr 1:49,327,621...49,348,435
Ensembl chr 1:49,327,296...49,348,435 		JBrowse link
G SLC22A5 solute carrier family 22 member 5 decreases activity EXP tebuconazole results in decreased activity of SLC22A5 protein CTD PMID:36669674 NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087 		JBrowse link
G SLC47A1 solute carrier family 47 member 1 decreases activity EXP tebuconazole results in decreased activity of SLC47A1 protein CTD PMID:36669674 NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946 		JBrowse link
G SLC47A2 solute carrier family 47 member 2 decreases activity EXP tebuconazole results in decreased activity of SLC47A2 protein CTD PMID:36669674 NCBI chr 5:40,491,306...40,515,430
Ensembl chr 5:40,491,933...40,540,136 		JBrowse link
troleandomycin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Troleandomycin results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347 		JBrowse link
verapamil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP [Verapamil results in decreased activity of ABCB1 protein] which affects the transport of Digoxin CTD PMID:20510202 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 494
    role 501
      biological role 494
        xenobiotic 41
          (-)-ephedrine 0
          (E)-roxithromycin 0
          (S)-nicotine + 0
          1,1-diunsubstituted alkanesulfonate + 0
          1,2,5,6,9,10-hexabromocyclododecane 0
          1-(3-(trifluoromethyl)phenyl)piperazine + 0
          1-(3-chlorophenyl)piperazine 0
          1-benzylpiperazine 0
          2,6-dichlorobenzonitrile 0
          2-methyl-4-chlorophenoxybutyric acid 0
          2-nitropropane 0
          3,4-dichloroaniline + 0
          3,5-dibromo-4-hydroxybenzonitrile 0
          3-iodoprop-2-yn-1-yl butylcarbamate 0
          3-methylquinoline 0
          4,5-dichloro-2-n-octyl-3(2H)-isothiazolone 0
          4-aminobenzenesulfonic acid 0
          5-fluorouracil 0
          5-methyl-1H-benzotriazole 0
          6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole + 0
          6:2 fluorotelomer unsaturated carboxylic acid 0
          6alpha-methylprednisolone + 0
          8:2 fluorotelomer unsaturated carboxylic acid 0
          N,N-diethyl-m-toluamide 0
          N-ethylperfluorooctane sulfonamidoacetic acid 0
          N-methylperfluorooctane sulfonamidoacetic acid 0
          acamprosate 0
          acesulfame 0
          acetamiprid + 0
          acetochlor 0
          acetophenone + 1
          aconine 0
          alachlor 0
          albuterol + 0
          alkanesulfinate + 0
          alprazolam 0
          amidotrizoic acid + 0
          aminophenazone 0
          amisulpride 0
          amitraz 0
          amitriptyline + 0
          amphetamine + 0
          antazoline 0
          antipyrine + 1
          arsenoacetic acid 0
          arsenocholine 0
          aspartame 0
          asulam 0
          atenolol + 1
          atomoxetine + 0
          atorvastatin 0
          atorvastatin calcium trihydrate 0
          atraton 0
          atrazine + 0
          azithromycin + 0
          azoxystrobin 0
          barbituric acid + 0
          bentazone 0
          benzo[d]isothiazol-3-one 0
          benzothiazole + 0
          benzotriazole + 0
          benzoylhypaconine 0
          bezafibrate 0
          bicalutamide 0
          bis(2-butoxyethyl)phthalate 0
          bisperfluorodecyl phosphate 0
          bisperfluorooctyl phosphate 0
          bisphenol A + 0
          boscalid + 0
          bromacil 0
          bupropion + 0
          butachlor 0
          caffeine + 0
          candesartan 0
          carbamazepine + 0
          carbetamide 0
          carpropamid + 0
          cetirizine 0
          chloral hydrate 0
          chloridazon 0
          chloromethylisothiazolinone + 0
          chlorotoluron 0
          chlorpyrifos 0
          chlorpyrifos-methyl 0
          cilastatin 0
          ciprofloxacin + 0
          citalopram 0
          clarithromycin 0
          climbazole 0
          clindamycin + 0
          clomazone 0
          clothianidin + 0
          clotrimazole 2
          clozapine 0
          cocaine 0
          codeine + 0
          crassicauline A 0
          cyanazine + 0
          cyanuric acid 0
          cyclophosphamide + 1
          cymoxanil 0
          cyproconazole 0
          cyprodinil 0
          decarbamoylsaxitoxin 0
          decylamine-N,N-dimethyl-N-oxide 0
          desmedipham 0
          dexamethasone + 3
          dextromethorphan + 2
          diazepam + 1
          diazinon 0
          dibenzodioxine + 4
          dibenzofuran + 0
          dicamba + 0
          dichlorprop 0
          diclocymet 0
          diclofenac + 2
          dieldrin 0
          difenoconazole 0
          diflufenican 0
          diglyme 0
          dimethachlor 0
          dimethenamid 0
          dimethoate 0
          dimethomorph 0
          dinoseb + 0
          diuron 0
          dodecyl sulfate + 0
          dronedarone 0
          eltrombopag 0
          endrin 0
          epoxiconazole 0
          eprosartan + 0
          erythromycin + 0
          ethambutol + 0
          ethofumesate 0
          exemestane 0
          fenofibrate 0
          fenoxanil 0
          fenoxycarb 0
          fenpropidin 0
          fenpropimorph 0
          fenuron 0
          fipronil 0
          flonicamid 0
          fluazifop 0
          fluazinam 0
          fluconazole + 0
          flufenacet 0
          flumequine 0
          fluometuron 0
          fluorenes + 0
          fluoxetine 0
          fluroxypyr + 0
          flusilazole 0
          foramsulfuron 0
          foresaconitine 0
          furosemide 0
          gabapentin + 0
          gemcitabine + 0
          hydrochlorothiazide 0
          hypaconine 0
          hypaphorine 0
          ibuprofen + 2
          ifosfamide 0
          imazamox 0
          imidacloprid + 0
          indan-1-ol + 0
          indometacin + 2
          iobitridol 0
          iohexol 0
          iomeprol 0
          iooxitalamic acid 0
          iopamidol 0
          iopromide 0
          ioxynil 0
          iprovalicarb 0
          irbesartan 0
          irgarol 1051 0
          isocyanuric acid + 0
          isoproturon 0
          ketamine + 0
          ketoprofen 0
          kresoxim-methyl 0
          lamotrigine 0
          lenacil 0
          levetiracetam 0
          lidocaine + 0
          linuron 0
          mecoprop 0
          mefenamic acid 0
          mephedrone 0
          mesotrione + 0
          metalaxyl 0
          metamitron + 0
          metazachlor 0
          metformin 0
          metformin hydrochloride + 0
          methadone + 0
          methamphetamine + 0
          methiocarb 0
          methomyl + 0
          methoxyfenozide 0
          metoclopramide 0
          metolachlor 0
          metoprolol 6
          metoxuron 0
          metribuzin 0
          metronidazole + 0
          metsulfuron methyl 0
          microcystin LF 0
          microcystin LW 0
          microcystin RR 0
          microcystin-LR 0
          moclobemide 0
          mono(5-carboxy-2-ethylpentyl) phthalate 0
          monuron 0
          morphine + 0
          myclobutanil 0
          mycophenolic acid + 0
          naltrexone 0
          naphthalene-2,7-disulfonic acid 0
          naphthalene-2-sulfonic acid 0
          napropamide 0
          naproxen + 0
          neohesperidin dihydrochalcone 0
          neotame 0
          nicosulfuron 0
          nitroglycerin 1
          norfloxacin 0
          norverapamil 0
          nylons 0
          octane + 0
          octhilinone 0
          orbencarb 0
          oseltamivir + 0
          oxazepam 0
          oxybenzone 0
          pantoprazole 1
          paracetamol + 3
          pentamidine 0
          perfluorobutyric acid 0
          perfluorodecanoic acid 0
          perfluorodecyl phosphate 0
          perfluoroheptanoic acid 0
          perfluorohexanoic acid 0
          perfluorononanoic acid 0
          perfluorooctane sulfonamidoacetic acid 0
          perfluorooctanoic acid 0
          perfluorooctyl phosphate 0
          perfluoropentanoic acid 0
          perfluoroundecanoic acid 0
          pethoxamide 0
          phenanthrenes + 1
          phenmedipham 0
          phenylhydrazine + 0
          pinoxaden 0
          pinoxaden acid + 0
          pioglitazone + 0
          pirimicarb 0
          pravastatin 0
          prednisolone + 0
          primidone 0
          prochloraz 2
          prometon 0
          prometryn 0
          propachlor 0
          propamocarb 0
          propane-2-sulfonate 0
          propaquizafop 0
          propazine 0
          propene + 0
          propiconazole 0
          propranolol + 4
          prosulfocarb 0
          prothioconazole 0
          pseudoephedrine 0
          pymetrozine 0
          pyraclostrobin 0
          pyrimethanil 0
          pyrocatechol sulfate 0
          pyrocatechol sulfate(1-) 0
          ranitidine + 0
          reserpine 0
          rimsulfuron 0
          ritonavir + 2
          rosuvastatin 0
          saccharin + 0
          sebuthylazine 0
          secbumeton 0
          simazine 0
          simeconazole 0
          simeton 0
          sitagliptin + 0
          sotalol 0
          spironolactone 7
          spiroxamine 0
          sucralose 0
          sulcotrione 0
          sulfadiazine 0
          sulfadimethoxine 0
          sulfamethazine + 0
          sulfamethoxazole + 0
          sulfapyridine 0
          sulfathiazole + 0
          sulfluramid 0
          synthetic auxin + 0
          systemic acquired resistance inducing compounds 0
          tebuconazole 4
          tebufenozide 0
          tebutam 0
          teflubenzuron 0
          telmisartan 0
          terbumeton 0
          terbutryn 0
          terbutylazine 0
          tetraconazole 0
          thiacloprid + 0
          thiamethoxam + 0
          thifensulfuron-methyl 0
          thiopental 0
          tramadol 0
          triadimefon 0
          trichlopyr 0
          triclocarban 0
          triclosan 0
          trifluralin 0
          trimethoprim + 0
          trimipramine + 0
          trinexapac-ethyl 0
          triphenylmethane + 0
          tritosulfuron 0
          troleandomycin 1
          tylosin 0
          uranyl hydrogenphosphate 0
          valsartan + 0
          venlafaxine + 0
          verapamil 1
          xenobiotic organic ethers 0
          yunaconitine 0
paths to the root